Eric Chow & Co, the Hong Kong association firm of PRC law firm Commerce & Finance Law Offices, has recruited capital markets expert Angela Zhang as a partner from Tian Yuan Law Firm.

Against a dynamic and rapidly evolving business landscape, dealmaking in Asia in the current year has been marked by resilience, innovation, and a strategic response to the challenges presented by the lingering effects of the COVID-19 pandemic. The region has continued to play a pivotal role in the global economy, with transaction lawyers navigating a complex terrain of geopolitical shifts and regulatory developments.

Tian Yuan Law Firm Hong Kong Office, which launched in 2016, continued to expand its Hong Kong capital markets practice through the past year even as the pandemic and Sino-U.S. tensions impacted capital flows.

Davis Polk & Wardwell and Tian Yuan Law Firm are advising China’s Youran Dairy on its planned IPO in Hong Kong, with Sidley Austin and Dentons advising the joint underwriters.

Wilson Sonsini Goodrich & Rosati and Han Kun Law Offices have advised Chinese dental brace maker Angelalign Technology on its $375 million IPO on the Hong Kong Stock Exchange, with Clifford Chance and Tian Yuan Law Firm advising the joint underwriters.

Skadden, Arps, Slate, Meagher & Flom and Commerce & Finance Law Offices have advised Chinese fintech firm Bairong on its $507 million IPO on the Hong Kong Stock Exchange, with Davis Polk & Wardwell and Tian Yuan Law Firm assisting the joint sponsors and underwriters.

Skadden, Arps, Slate, Meagher & Flom, Tian Yuan Law Firm and Conyers have advised China’s New Oriental Education & Technology on its HK$10.13 billion ($1.31 billion) secondary offering on the Hong Kong Stock Exchange, with Herbert Smith Freehills and Jia Yuan Law Offices counselling the joint sponsors and underwriters.

O'Melveny & Myers, Tian Yuan Law Firm and William Ji & Co. have represented China’s Simcere Pharmaceutical Group on its HK$3.57 billion ($460.6 million) Hong Kong IPO, with Herbert Smith Freehills and Jingtian & Gongcheng advising the joint sponsors.

Skadden, Arps, Slate, Meagher & Flom and Zhong Lun Law Firm have advised China’s Everest Medicines on its $451 million IPO in Hong Kong, with Kirkland & Ellis and Tian Yuan Law Firm advising the joint sponsors and underwriters.

Freshfields Bruckhaus Deringer and Jingtian & Gongcheng have advised Chinese bottled water and beverage company Nongfu Spring's on its $1.08 billion initial public offering on the Hong Kong Stock Exchange, with Clifford Chance and Tian Yuan Law Firm representing the joint sponsors and underwriters.